molecular profiling
BostonGene, Sarah Cannon Research Institute Partner to Add Molecular Testing to Clinical Trials
The partners will incorporate BostonGene's Tumor Portrait tests into SCRI's Phase I clinical trials to explore the use of HLA typing for pre-screening patients.
BostonGene, Takeda Form Immunotherapy Clinical Research Partnership
The firms will apply BostonGene's AI-driven multiomics platform to identify molecular drivers of cancer and predictive markers of treatment response.
BostonGene, Sylvester Comprehensive Cancer Center Partner on Hematologic Cancer Molecular Subtyping
Researchers will compare traditional tumor profiling methods such as FISH and cytogenetics to BostonGene's AI-powered molecular and immune profiling platform.
The partners hope to expand the Alabama Cancer Care program after pilot data showed point-of-care expert reviews of genomic test results influence patient care.
Genomate Health Raises $2.25M for AI-Based Model to Predict Targeted Cancer Therapy Response
The firm plans to pursue FDA clearance to market its AI-driven model for prediction of patient response to cancer therapy.